Brief: Astellas Enters Into Definitive Agreement To Acquire Iveric Bio
April 30 (Reuters) - IVERIC bio Inc ISEE.O :
* ASTELLAS ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE
IVERIC BIO
* IVERIC BIO INC SAYS ACQUISITION PRICE OF US$40 PER SHARE
IN
CASH, REPRESENTING A TOTAL EQUITY VALUE OF APPROXIMATELY US$5.9
BILLION
* IVERIC BIO INC SAYS IVERIC BIO WILL BECOME AN INDIRECTLY
WHOLLY-OWNED SUBSIDIARY OF ASTELLAS
Source text for Eikon: ID:nBw7NY0W8a
Further company coverage: ISEE.O
((reuters.briefs@thomsonreuters.com;))
Recent news on IVERIC bio
See all newsBrief: Astellas Pharma Inc - Astellas Completes Acquisition Of Iveric Bio
Analysis: Amgen's antitrust woes spur wider pharmaceutical deal fears
Iveric Bio Inc Reports Results For The Quarter Ended In March: Earnings Summary
The end of cheap credit could hurry Japanese M&A
U.S. STOCKS ON THE MOVE-US banks, Biomea Fusion, Tutor Perini